Subhamoy Dasgupta

Title: Subhamoy Dasgupta: Innovator in Prostate Cancer Treatment

Introduction

Subhamoy Dasgupta is a notable inventor based in Houston, Texas, recognized for his contributions to the field of cancer research. He has developed innovative methods for diagnosing and treating metastatic prostate cancer, which is a significant health concern for many individuals.

Latest Patents

Dasgupta holds a patent for the use of SRC-2 as a metabolic biomarker for the diagnosis and treatment of metastatic prostate cancer. This patent outlines methods and compositions that provide effective therapy for individuals with elevated levels of SRC-2, also known as NCOA2 or GRIP1 TIF2. The invention focuses on assessing samples from individuals diagnosed with prostate cancer to determine their risk of developing metastatic prostate cancer and administering appropriate therapies based on these findings.

Career Highlights

Dasgupta is affiliated with Baylor College of Medicine, where he conducts research and develops innovative solutions for cancer treatment. His work has the potential to significantly impact the lives of patients suffering from prostate cancer by providing targeted therapies based on metabolic biomarkers.

Collaborations

Dasgupta collaborates with esteemed colleagues, including Bert W O'Malley and Nicholas Mitsiades, to advance research in cancer treatment and improve patient outcomes.

Conclusion

Subhamoy Dasgupta's innovative work in the field of prostate cancer treatment exemplifies the importance of research and development in medicine. His contributions through patented methods are paving the way for more effective therapies and better diagnostic tools for patients.